Jaguar Health, Inc. JAGX
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$2.06$2.24
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -93.95% | 525.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -93.96% | 526.65% | |||
| Cost of Revenue | -10.97% | -47.36% | |||
| Gross Profit | -98.99% | 1,746.76% | |||
| SG&A Expenses | -10.97% | -30.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.57% | -57.38% | |||
| Operating Income | -174.61% | 149.81% | |||
| Income Before Tax | -246.76% | 137.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -246.76% | 137.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.76% | -4.55% | |||
| Net Income | -243.32% | 138.37% | |||
| EBIT | -174.61% | 149.81% | |||
| EBITDA | -166.86% | 153.37% | |||
| EPS Basic | -15.42% | 91.12% | |||
| Normalized Basic EPS | -160.77% | 112.63% | |||
| EPS Diluted | -15.42% | 91.12% | |||
| Normalized Diluted EPS | -160.77% | 112.63% | |||
| Average Basic Shares Outstanding | 56.69% | 240.59% | |||
| Average Diluted Shares Outstanding | 56.69% | 240.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||